Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Status:
Recruiting
Trial end date:
2025-05-30
Target enrollment:
Participant gender:
Summary
This is a master protocol designed to evaluate the safety and efficacy of investigational
therapies in participants with metastatic castration-resistant prostate cancer (mCRPC).